MAPT and Alzheimer disease: K163, K174, K180, and other lysine sites of Tau can be acetylated by p300, which inhibits normal ubiquitination‐dependent protein degradation and microtubule assembly and promotes abnormal aggregation of Tau protein, leading to neurodegenerative diseases such as AD (Figure 5).328